高MCM6表达促进增殖,并与三阴性乳腺癌的不良预后相关
1Department of Surgical Oncology, Provincial Clinical College of Fujian Medical University, Fuzhou, China. wangqingshui@fjnu.edu.cn.
European review for medical and pharmacological sciences
|April 19, 2024
概括
微染色体维护基因 (MCMs) 在三阴性乳腺癌 (TNBC) 中过度表达,高MCM6与预后不佳有关. 使用MCM6相关基因的新风险模型可能有助于TNBC治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 三阴性乳腺癌 (TNBC) 是一种具有攻击性的亚型,治疗选择有限,预后不佳.
- 微染色体维护基因 (MCM2-7),对于DNA复制至关重要,与各种癌症有关,但在TNBC中未得到充分研究.
- 了解MCM基因角色可以识别TNBC的新生物标志物和治疗点.
研究的目的:
- 研究TNBC中MCM2-7基因的表达和预后意义.
- 阐明MCM6在TNBC细胞增殖中的功能作用及其与细胞周期的关联.
- 开发基于MCM6相关基因的TNBC患者生存预测风险模型.
主要方法:
- 在四个与TNBC相关的GEO数据库中分析MCM2-7基因表达.
- 单细胞分析和基因组丰富分析 (GSEA) 探索MCM6功能.
- 使用CCK8试验和癌症依赖地图数据评估MCM6对TNBC细胞增殖的影响.
- 使用WGCNA和LASSO考克斯回归构建一个风险评分模型.
主要成果:
- 与正常的邻近组织相比,TNBC组织中的MCM2-7基因被显著上调.
- 高MCM6表达与TNBC患者的生存时间缩短相关,并与细胞循环通路激活有关.
- 抑制MCM6抑制了TNBC细胞的增殖.
- 结合MCM6,CDC23和CCNB1的预测风险模型在预测TNBC患者存活率方面表现出有效性.
结论:
- 在TNBC中MCM6的过度表达与更糟糕的预后有关,并导致细胞增殖的增加.
- Knockdown 的 MCM6 抑制 TNBC 细胞增殖,表明其作为治疗点的潜力.
- 一种基于MCM6和相关基因的新型风险评分模型可以预测TNBC患者的预后,为改善治疗策略提供了潜力.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


